PERSPECTA

News from every angle

Back to headlines

Novo Nordisk CEO Resets Expectations for Wegovy Growth

The CEO of Novo Nordisk has adjusted expectations for the explosive growth of its popular weight-loss drug, Wegovy.

6 Aug, 22:03 — 6 Aug, 22:03
PostShare